#4 lessons from blockbuster failure david reiss trial#
Urine LAM Testing in Advanced HIV Positive Adults in a Trial of Empiric TB Therapy. Matoga MM, Bisson GP, Gupta A, Miyahara S, Sun X, Fry C, Manabe YC, Kumwenda J, Cecilia K, Nyirenda M, Ngongondo M, Mbewe A, Lagat D, Wallis C, Mugerwa H, HosseinipourMC.Matoga MM, et al.January 2022 Journal of the International AIDs Society Volume 25 Juchnowski SM, Zidar DA, McComsey GA, Kityo C. Longenecker CT, Bogorodskaya M, Margevicius S, Nazzinda R,īittencourt MS, Erem G, Nalukwago S, Huaman MA, Ghoshhajra BB, Siedner MJ, 00587-3īetween HIV and coronary artery disease among older adults in Uganda. , ReducedĪnd highly diverse peripheral HIV-1 reservoir in virally suppressed patients infected with non-B HIV-1 strains in Uganda. Joussef-Piña S, Nankya I, Nalukwago S, Baseke J, Rwambuya S, Winner D, Kyeyune F,Ĭhervenak K, Thiel B, Asaad R, Dobrowolski C, Luttge B, Lawley B, Kityo CM, Boom WH, Karn J, Quiñones-Mateu ME. Virally suppressed patients infected with non-B HIV-1 strains in Uganda. Reduced and highly diverse peripheral HIV-1 reservoir in The Lancet Gastroenterology&Hepatology 1253(21)00397-6. Supparatpinyo K, Kityo C, Tebas P, Bennet JA, Santana-Bagur J,īenson CA,Van Schalkwyk M, Cheinquer N, Naggie S, Wyles D, Sulkowski M.A minimal monitoring approach for the treatment of hepatitis. Wagner-Cardoso S, Smeaton L, Sowah LA, Wimbish C, Robbins G, Brates I, ScelloĬ, Son A, Avihingsanon A, Linas B, Anthony D, Nunes EP, Kliemann DA, 2021.PMID: 33177204Free article.Īminimal monitoring approach for the treatment of hepatitis C virus infection (ACTGĪ5360 ): a phase 4, open-label, single-arm trial. Deep Gene Sequence Cluster Analyses of Multi-Virus-Infected Mucosal Tissue Reveal Enhanced Transmission of Acute HIV-1.Klein K, Nankya I, Nickel G, Ratcliff AN, Meadows AAJ, Hathaway N, Bailey JA, Stieh DJ, Cheeseman HM, Carias AM, Lobritz MA, Mann JFS, Gao Y, Hope TJ, Shattock RJ, Arts EJ.Klein K, et al.Factors associated with virological non-suppression among HIV-positive children receiving antiretroviral therapy at the Joint Clinical Research Centre in Lubowa, Kampala Uganda.Nabukeera S, Kagaayi J, Makumbi FE, Mugerwa H, MatovuJKB.ODYSSEY clinical trial design: a randomized global study to evaluate the efficacy and safety of dolutegravir-based antiretroviral therapy in HIV-positive children, with nested pharmacokinetic sub-studies to evaluate pragmatic WHO-weight-band based dolutegravirdosing.Moore CL, Turkova A, Mujuru H, Kekitiinwa A, Lugemwa A, Kityo CM, Barlow-Mosha LN, Cressey TR, Violari A, Variava E, Cotton MF, Archary M, Compagnucci A, Puthanakit T, Behuhuma O, Saϊdi Y, Hakim J, Amuge P, Atwine L, Musiime V, Burger DM, Shakeshaft C, Giaquinto C, Rojo P, Gibb DM, Ford D ODYSSEY Trial Team.New Insights on Long-Term Hepatitis B Virus Responses in HIV-Hepatitis B virus Co-infected Patients: Implications for Antiretroviral Management in Hepatitis B virus-Endemic Settings.Dunn D, Price H, Vudriko T, Kityo C, Musoro G, Hakim J, Gilks C, Kaleebu P, Pillay D, Gilson R DART Virology Group.The Association of Kidney Disease with Abnormal Cardiac Structure and Function among Ugandans with HIV InfectionMatthew Peters, SeungheeMargevicius, Cissy Kityo, Grace Mirembe, Jonathan Buggey, Ellen Brinza, Mark Schluchter, Chun-Ho Yun, Chung-Lieh Hung, Grace A McComsey, Chris T Longenecker.Failure is not an option: Barriers to HIV treatment adherence in Kampala, Uganda Bruser G, Katasi R, Zhang LZ, Namasinga M, Arts E, Kityo C, Luginaah I.
0 kommentar(er)
